BACKGROUND/AIMS: Accurate diagnosis of sporadic early-onset Alzheimer's disease (EOAD) can be challenging, and cerebrospinal fluid (CSF) biomarkers may assist in this process. We compared CSF indices between three EOAD subtypes: amnestic, logopenic progressive aphasia (LPA), and posterior cortical atrophy (PCA). METHODS: We identified 21 amnestic EOAD, 20 LPA, and 12 PCA patients with CSF data, which included amyloid β1-42 (Aβ42), total tau (t-tau), phospho-tau181 (p-tau), and Aβ42/t-tau index (ATI) levels. RESULTS: Aβ42 and ATI levels were similar across groups, but t-tau and p-tau levels were significantly lower in PCA patients. CONCLUSIONS: The Aβ42 and ATI data confirm the commonality of the Aβ pathology in EOAD. The lower tau indices in PCA patients may reflect differences in the distribution of neurofibrillary tangles or rates of neurodegeneration.
BACKGROUND/AIMS: Accurate diagnosis of sporadic early-onset Alzheimer's disease (EOAD) can be challenging, and cerebrospinal fluid (CSF) biomarkers may assist in this process. We compared CSF indices between three EOAD subtypes: amnestic, logopenic progressive aphasia (LPA), and posterior cortical atrophy (PCA). METHODS: We identified 21 amnestic EOAD, 20 LPA, and 12 PCApatients with CSF data, which included amyloid β1-42 (Aβ42), total tau (t-tau), phospho-tau181 (p-tau), and Aβ42/t-tau index (ATI) levels. RESULTS: Aβ42 and ATI levels were similar across groups, but t-tau and p-tau levels were significantly lower in PCApatients. CONCLUSIONS: The Aβ42 and ATI data confirm the commonality of the Aβ pathology in EOAD. The lower tau indices in PCApatients may reflect differences in the distribution of neurofibrillary tangles or rates of neurodegeneration.
Authors: Esther L G E Koedam; Yolande A L Pijnenburg; Dorly J H Deeg; Merel M E Baak; Annelies E van der Vlies; Philip Scheltens; Wiesje M van der Flier Journal: Dement Geriatr Cogn Disord Date: 2008-08-04 Impact factor: 2.959
Authors: Thomas P Baumann; Hüseyin Duyar; Marc Sollberger; Jens Kuhle; Axel Regeniter; Baltazar Gomez-Mancilla; Klaus Schmidtke; Andreas U Monsch Journal: Dement Geriatr Cogn Disord Date: 2010-07-01 Impact factor: 2.959
Authors: W T Hu; C McMillan; D Libon; S Leight; M Forman; V M-Y Lee; J Q Trojanowski; M Grossman Journal: Neurology Date: 2010-08-17 Impact factor: 9.910
Authors: Leslie M Shaw; Hugo Vanderstichele; Malgorzata Knapik-Czajka; Christopher M Clark; Paul S Aisen; Ronald C Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski Journal: Ann Neurol Date: 2009-04 Impact factor: 10.422
Authors: M I Kester; A E van der Vlies; M A Blankenstein; Y A L Pijnenburg; E J van Elk; P Scheltens; W M van der Flier Journal: Neurology Date: 2009-10-27 Impact factor: 9.910
Authors: Harald Hampel; Kaj Blennow; Leslie M Shaw; Yvonne C Hoessler; Henrik Zetterberg; John Q Trojanowski Journal: Exp Gerontol Date: 2009-10-22 Impact factor: 4.032
Authors: Rik Ossenkoppele; Niklas Mattsson; Charlotte E Teunissen; Frederik Barkhof; Yolande Pijnenburg; Philip Scheltens; Wiesje M van der Flier; Gil D Rabinovici Journal: Neurobiol Aging Date: 2015-04-25 Impact factor: 4.673
Authors: Katheryn A Q Cousins; David J Irwin; David A Wolk; Edward B Lee; Leslie M J Shaw; John Q Trojanowski; Fulvio Da Re; Garrett S Gibbons; Murray Grossman; Jeffrey S Phillips Journal: Brain Date: 2020-07-01 Impact factor: 13.501
Authors: Ross W Paterson; Jamie Toombs; Catherine F Slattery; Jennifer M Nicholas; Ulf Andreasson; Nadia K Magdalinou; Kaj Blennow; Jason D Warren; Cath J Mummery; Martin N Rossor; Michael P Lunn; Sebastian J Crutch; Nick C Fox; Henrik Zetterberg; Jonathan M Schott Journal: J Neurol Date: 2015-09-26 Impact factor: 4.849